Kukje Pharma Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Kukje Pharma Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Kukje Pharma Co Ltd (002720) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.99 Billion ≈ $3.38 Million USD) by net assets (₩95.32 Billion ≈ $64.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kukje Pharma Co Ltd (2011–2024)

Cash flow conversion efficiency of Kukje Pharma Co Ltd from 2011 to 2024. This chart illustrates how Kukje Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Kukje Pharma Co Ltd share price for real-time trading data and today's change.

Kukje Pharma Co Ltd Cash Flow Conversion Ratio Explained

Kukje Pharma Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kukje Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kukje Pharma Co Ltd ranked by their cash flow conversion efficiency. Also see 002720 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Annovis Bio Inc NYSE:ANVS	-2.883x
Delta Technologies Nyrt BUD:DELTA	N/A
Euro Sun Mining Inc TO:ESM	0.204x
Bali Bintang Sejahtera Tbk PT JK:BOLA	-0.009x
Do Day Dream Public Company Limited BK:DDD	-0.001x
SAMYOUNG M-Tek Co. Ltd KQ:054540	0.013x
Supra Boga Lestari Tbk JK:RANC	0.149x
Beijing North Star Company Limited F:BJ3	0.078x

Annual Cash Flow Conversion Efficiency for Kukje Pharma Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Kukje Pharma Co Ltd from 2011 to 2024. Review Kukje Pharma Co Ltd (002720) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩89.55 Billion ≈ $60.69 Million	₩3.94 Billion ≈ $2.67 Million	0.044x	+4.54%
2023-12-31	₩84.95 Billion ≈ $57.57 Million	₩3.58 Billion ≈ $2.42 Million	0.042x	-52.06%
2022-12-31	₩74.08 Billion ≈ $50.20 Million	₩6.50 Billion ≈ $4.41 Million	0.088x	-37.26%
2021-12-31	₩68.59 Billion ≈ $46.48 Million	₩9.60 Billion ≈ $6.50 Million	0.140x	+93.42%
2020-12-31	₩70.50 Billion ≈ $47.78 Million	₩5.10 Billion ≈ $3.46 Million	0.072x	+22.36%
2019-12-31	₩60.95 Billion ≈ $41.31 Million	₩3.60 Billion ≈ $2.44 Million	0.059x	-69.34%
2018-12-31	₩68.70 Billion ≈ $46.56 Million	₩13.25 Billion ≈ $8.98 Million	0.193x	+1562.80%
2017-12-31	₩67.78 Billion ≈ $45.93 Million	₩786.10 Million ≈ $532.73K	0.012x	-95.14%
2016-12-31	₩67.52 Billion ≈ $45.76 Million	₩16.10 Billion ≈ $10.91 Million	0.238x	+421.30%
2015-12-31	₩68.46 Billion ≈ $46.39 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.074x	-6075.28%
2014-12-31	₩50.85 Billion ≈ $34.46 Million	₩-61.11 Million ≈ $-41.41K	-0.001x	+98.47%
2013-12-31	₩58.33 Billion ≈ $39.53 Million	₩-4.60 Billion ≈ $-3.11 Million	-0.079x	-376.04%
2012-12-31	₩55.35 Billion ≈ $37.51 Million	₩1.58 Billion ≈ $1.07 Million	0.029x	-87.72%
2011-12-31	₩74.79 Billion ≈ $50.69 Million	₩17.39 Billion ≈ $11.78 Million	0.232x	--

About Kukje Pharma Co Ltd

KO:002720 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$46.37 Million

₩68.42 Billion KRW

Market Cap Rank

#21989 Global

#1353 in Korea

Share Price

₩3360.00

Change (1 day)

-2.04%

52-Week Range

₩3045.00 - ₩5230.00

All Time High

₩12612.03